These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 367088)

  • 1. Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system.
    Henningsen NC; Mattiasson I
    Acta Med Scand; 1979; 205(1-2):61-6. PubMed ID: 367088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Jameson S; Henningsen NC
    Acta Med Scand; 1976; 199(4):257-61. PubMed ID: 4956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of atenolol in hypertension.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Henningsen NC; Jameson S
    Clin Sci Mol Med Suppl; 1976 Dec; 3():513s-515s. PubMed ID: 799559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.
    Hansson L; Westerlund A; Aberg H; Karlberg BE
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):361-5. PubMed ID: 786662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
    England JD
    Aust N Z J Med; 1981 Feb; 11(1):35-40. PubMed ID: 7018482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
    Lund-Johansen P
    Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atenolol and bendrofluazide in hypertension.
    Petrie JC; Galloway DB; Webster J; Simpson WT; Lewis JA
    Br Med J; 1975 Oct; 4(5989):133-5. PubMed ID: 1104047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Jun; 17(6):425-60. PubMed ID: 38096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
    G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol (Tenormin) - another "cardioselective" beta-blocker for hypertension.
    Med Lett Drugs Ther; 1982 Feb; 24(602):15-6. PubMed ID: 7057740
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension.
    Fodor JG; Chockalingam A; Drover A; Fifield F; Pauls CJ
    J Clin Pharmacol; 1987 Nov; 27(11):892-901. PubMed ID: 2892865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
    Stensrud P; Sjaastad O
    Headache; 1980 Jul; 20(4):204-7. PubMed ID: 6993420
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
    De Plaen JF; Amery A; Reybrouck T
    Eur J Clin Pharmacol; 1976 Sep; 10(5):297-303. PubMed ID: 789082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
    J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta adrenergic blocking agents to control hypertension in aviation personnel.
    Schamroth CL; Davidoff R; Schamroth JM; Myburgh DP
    Aviat Space Environ Med; 1982 Apr; 53(4):403-4. PubMed ID: 6123307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atenolol and three nonselective beta-blockers in hypertension.
    Waal-Manning HJ
    Clin Pharmacol Ther; 1979 Jan; 25(1):8-18. PubMed ID: 31259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical testing of a new beta blocking agent--atenolol--in hypertension].
    Hansson L; Henningsen NC; Jameson S; Karlberg BE; Westerlund A; Aberg H
    Lakartidningen; 1976 Aug; 73(34):2741-4. PubMed ID: 787700
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and haemodynamic study of atenolol (Tenormin) in essential hypertension.
    Jensen HA; Rasmussen K; Mosbaek N
    Clin Sci Mol Med Suppl; 1976 Dec; 3():525s-526s. PubMed ID: 799562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.